Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this clinical trial is to investigate the
safety, tolerability, pharmacokinetics and pharmacodynamics of NNC126-0083 in growth hormone
deficient adults